Skip to content
Metoclopramide
Gimoti, Reglan (metoclopramide) is a small molecule pharmaceutical. Metoclopramide was first approved as Reglan on 1982-01-01. It is used to treat gastroesophageal reflux, gastroparesis, and postoperative nausea and vomiting in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 4 and D(2) dopamine receptor. In addition, it is known to target 5-hydroxytryptamine receptor 3A.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
digestive system diseasesD004066
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Gimoti, Reglan (generic drugs available since 1985-07-29, discontinued: Clopra, Clopra-yellow, Maxolon, Metozolv)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Metoclopramide hydrochloride
Tradename
Company
Number
Date
Products
REGLANANI PHARMSN-017854 RX1982-01-01
2 products, RLD, RS
GIMOTIEvoke PharmaN-209388 RX2020-06-19
1 products, RLD, RS
Show 4 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
gimotiNew Drug Application2021-01-07
metoclopramideANDA2023-06-07
reglanNew Drug Application2020-06-19
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
gastroesophageal refluxEFO_0003948D005764K21
gastroparesisEFO_1000948D018589K31.84
postoperative nausea and vomitingEFO_0004888D020250
Agency Specific
FDA
EMA
Expiration
Code
METOCLOPRAMIDE HYDROCHLORIDE, GIMOTI, EVOKE PHARMA INC
2023-06-19NP
Patent Expiration
Patent
Expires
Flag
FDA Information
Metoclopramide Hydrochloride, Gimoti, Evoke Pharma Inc
83342812030-05-16DPU-2843
110203612029-12-22U-2843
116281502029-12-22DPU-2843
ATC Codes
A: Alimentary tract and metabolism drugs
A03: Drugs for functional gastrointestinal disorders
A03F: Propulsives
A03FA: Propulsives
A03FA01: Metoclopramide
HCPCS
Code
Description
J2765
Injection, metoclopramide hcl, up to 10 mg
Clinical
Clinical Trials
127 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Migraine disordersD008881EFO_0003821G43258318
VomitingD014839HP_0002013R11.11267117
NauseaD009325HP_0002018R11.038213
HeadacheD006261HP_0002315R5113115
NeoplasmsD009369C802114
Postoperative nausea and vomitingD020250EFO_00048881113
Post-traumatic headacheD051298G44.311113
VertigoD014717H81.39112
Psychomotor agitationD011595112
Gastroesophageal refluxD005764EFO_0003948K21112
Show 22 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
GastroparesisD018589EFO_1000948K31.842215
Breast feedingD001942112
Myeloid leukemia acuteD015470C92.011
Hiv infectionsD015658EFO_0000764B2011
GastroschisisD020139EFO_1000949Q79.311
SepsisD018805A41.911
AnemiaD000740EFO_0004272D64.911
Gastrointestinal hemorrhageD006471K92.211
Intraoperative complicationsD00743111
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diabetes mellitusD003920EFO_0000400E08-E1322
Hyperemesis gravidarumD006939EFO_1000971O2122
Enteral nutritionD00475022
HypoglycemiaD007003HP_0001943E16.211
Myelodysplastic syndromesD009190D4611
Drug-related side effects and adverse reactionsD064420T88.711
Wounds and injuriesD014947T14.811
Radiation exposureD00006907911
Newborn infant diseasesD00723211
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Autonomic nervous system diseasesD001342EFO_0009532G9011
Orthostatic hypotensionD007024I95.111
Orthostatic intoleranceD05497111
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypotensionD007022EFO_0005251I9522
RhytidoplastyD01536111
Fertilization in vitroD00530711
ObesityD009765EFO_0001073E66.911
Pregnancy rateD01887311
Deglutition disordersD003680HP_0002015R13.111
Liver cirrhosisD008103EFO_0001422K74.011
Colorectal neoplasmsD01517911
HyperlactatemiaD06590611
Altitude sicknessD000532EFO_1000782T70.2911
Show 3 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameMETOCLOPRAMIDE
INNmetoclopramide
Description
Metoclopramide is a member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine. It has a role as an antiemetic, a dopaminergic antagonist, a gastrointestinal drug, a xenobiotic and an environmental contaminant. It is a tertiary amino compound, a substituted aniline, a member of benzamides and a member of monochlorobenzenes. It is a conjugate base of a metoclopramide(1+).
Classification
Small molecule
Drug classD2 receptor antagonist; 5-HT3 receptor antagonist; 5-HT4 receptor agonist; Prolactin releaser
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC
Identifiers
PDB
CAS-ID364-62-5
RxCUI6915
ChEMBL IDCHEMBL86
ChEBI ID107736
PubChem CID4168
DrugBankDB01233
UNII IDL4YEB44I46 (ChemIDplus, GSRS)
Target
Agency Approved
HTR4
HTR4
DRD2
DRD2
Organism
Homo sapiens
Gene name
HTR4
Gene synonyms
NCBI Gene ID
Protein name
5-hydroxytryptamine receptor 4
Protein synonyms
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled, cardiac 5-HT4 receptor, Serotonin receptor 4
Uniprot ID
Mouse ortholog
Htr4 (15562)
5-hydroxytryptamine receptor 4 (Q9R2A4)
Alternate
HTR3A
HTR3A
Organism
Homo sapiens
Gene name
HTR3A
Gene synonyms
5HT3R, HTR3
NCBI Gene ID
Protein name
5-hydroxytryptamine receptor 3A
Protein synonyms
5-HT-3, 5-HT3R, 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic, 5-hydroxytryptamine receptor 3, 5HT3 serotonin receptor, Serotonin receptor 3A, Serotonin-gated ion channel receptor
Uniprot ID
Mouse ortholog
Htr3a (15561)
5-hydroxytryptamine receptor 3A (Q61226)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 11,907 documents
View more details
Safety
Black-box Warning
Black-box warning for: Gimoti, Metoclopramide, Reglan
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
5,001 adverse events reported
View more details